Unlocking the Therapeutic Potential from the Development of Targeted Radiopharmaceutical Therapies
- Introducing targeted radiopharmaceutical (TRP) development through protein engineering with a novel linker chelator and differentiated radioisotope payload
- Understanding favorable characteristics of TRPs including applications across low and high tumor target expression
- Exploring the potential of TRP therapies to deliver clinical benefit versus conventional drug conjugates